MN Rochester의 폐암 임상 시험
폐암 관련 연구 20개가 Rochester 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
피험자 모집 중2상
- Mayo Clinic, Rochester
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
피험자 모집 중3상
- Mayo Clinic - Rochester ( Site 0073), Rochester
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
피험자 모집 중2/3상
- Mayo Clinic in Rochester, Minnesota, Rochester
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care
피험자 모집 중관찰 연구
- Mayo Clinic in Rochester, Rochester
A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer
피험자 모집 중건강한 지원자 환영
- Mayo Clinic in Rochester, Rochester
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
피험자 모집 중3상
- Mayo Clinic, Rochester
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
피험자 모집 중3상
- Mayo Clinic in Rochester, Rochester
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
피험자 모집 중3상
- Mayo Clinic in Rochester, Rochester
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
피험자 모집 중1상
- Xencor Investigative Site, Rochester
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
피험자 모집 중관찰 연구
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
피험자 모집 중1/2상
- Mayo Clinic Rochester, Rochester
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
피험자 모집 중
- Mayo Clinic, Rochester
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
피험자 모집 중1/2상
- Mayo Clinic Cancer Center, Rochester
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
피험자 모집 중1/2상
- Mayo Clinic Cancer Center, Rochester
Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer
피험자 모집 중2상
- Mayo Clinic in Rochester, Rochester
Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
피험자 모집 중2상
- Mayo Clinic in Rochester, Rochester
Insomnia in Patients With Metastatic Lung Cancer
피험자 모집 중관찰 연구
- Mayo Clinic in Rochester, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
피험자 모집 중관찰 연구건강한 지원자 환영
- Mayo Clinic, Rochester
Thoracic Specimen Registry
피험자 모집 중관찰 연구
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
피험자 모집 중1/2상
- Mayo Clinic, Rochester
다른 도시의 폐암 시험
- Houston, TX연구 78개
- Boston, MA연구 62개
- New York City, NY연구 60개
- Los Angeles, CA연구 45개
- Washington, DC연구 41개
- Chicago, IL연구 41개
- Nashville, TN연구 40개
- Arlington, VA연구 40개
- Baltimore, MD연구 40개
- St. Louis, MO연구 39개
- Columbus, OH연구 36개
- Philadelphia, PA연구 36개
Rochester의 다른 연구
- 유방암연구 42개
- 비소세포폐암연구 37개
- 암 (전체)연구 30개
- 전이성 암연구 30개
- 난소암연구 29개
- 대장직장암연구 29개
- 다발성 골수종연구 24개
- 췌장암연구 23개
- 심부전연구 22개
- 전립선암연구 22개
- 자궁내막암연구 19개
- 만성 림프구성 백혈병연구 19개
ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.